UNIOVI-PEDIATRIA
OVIPED
Centro de Investigación Médica Aplicada
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Médica Aplicada (11)
2019
-
The SRC inhibitor dasatinib induces stem cell-like properties in head and neck cancer cells that are effectively counteracted by the mithralog EC-8042
Journal of Clinical Medicine, Vol. 8, Núm. 8
2016
-
Assessing the role of TUBA4A gene in frontotemporal degeneration
Neurobiology of Aging, Vol. 38, pp. 215.e13-215.e14
2015
-
Analysis of the CHCHD10 gene in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Spain
Brain
-
Convergent genetic and expression data implicate immunity in Alzheimer's disease
Alzheimer's and Dementia, Vol. 11, Núm. 6, pp. 658-671
-
MAPT H1 haplotype is associated with late-onset Alzheimer's disease risk in APOE ε 4 noncarriers: Results from the dementia genetics Spanish consortium
Journal of Alzheimer's Disease, Vol. 49, Núm. 2, pp. 343-352
2014
-
Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia
Neurobiology of Aging, Vol. 35, Núm. 2, pp. 444.e1-444.e4
-
Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease
PLoS ONE, Vol. 9, Núm. 6
2013
-
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Nature Genetics, Vol. 45, Núm. 12, pp. 1452-1458
-
Mutational screening of PARKIN identified a 3′ UTR variant (rs62637702) associated with parkinson's disease
Journal of Molecular Neuroscience, Vol. 50, Núm. 2, pp. 264-269
2012
-
A search for SNCA 3′ UTR variants identified SNP rs356165 as a determinant of disease risk and onset age in Parkinson's disease
Journal of Molecular Neuroscience, Vol. 47, Núm. 3, pp. 425-430
2011
-
Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease
Movement Disorders, Vol. 26, Núm. 5, pp. 819-823